Directly observed therapy (DOT)

BEHAVIORAL3 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID), Massachusetts General Hospital, Medecins Sans Frontieres, Netherlands

Conditions

DepressionHIV InfectionsMultidrug Resistant Tuberculosis

Phase 2

Antidepressant Medication Plus Directly Observed Therapy for Improving Adherence to Antiretroviral Therapy

CompletedNCT00338767

Massachusetts General HospitalDepression, HIV Infections

Start: 2001-01-31End: 2006-08-31Updated: 2013-11-15

Unknown Phase

Directly Observed Therapy for HIV Infected Adolescents

CompletedNCT00259389

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections

Start: 2006-04-30End: 2007-09-30Target: 24Updated: 2012-09-18

Patient-reported Experiences and Quality of Life Outcomes in the TB-PRACTECAL Clinical Trial

CompletedNCT03942354

Medecins Sans Frontieres, NetherlandsMultidrug Resistant Tuberculosis

Start: 2019-09-01End: 2022-05-10Updated: 2024-05-29

Related Papers

Capturing patient-reported and quality of life outcomes with use of shorter regimens for drug-resistant tuberculosis: mixed-methods substudy protocol, TB PRACTECAL-PRO

BMJ Open2021-09-019 citations

Does substance use compromise depression treatment in persons with HIV? Findings from a randomized controlled trial

AIDS Care2016-09-0211 citations